EarningsQ4 2022 Earnings Report

Santhera Pharmaceuticals Holding (SPHDF) Q4 2022 Earnings Report

40 Followers

SPHDF Q4 2022 EPS Results

Actual EPS-$2.56

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$2.76

Actual Revenue$1.47M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+120.09%

QuarterQ4 2022

Date04/27/2023

TimeBefore Open

Conference CallThursday, April 27, 2023

SPHDF Upcoming Earnings

Santhera Pharmaceuticals Holding's next earnings date is estimated for April 29, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 29, 2027	2026 (Q4)	- / -	-0.516	―
Sep 30, 2026	2026 (Q2)	0.20 / -0.11	-0.444	75.68% (+0.34)
Apr 28, 2026	2025 (Q4)	-0.52 / -0.52	-0.888	41.89% (+0.37)
Sep 23, 2025	2025 (Q2)	-0.72 / -3.65	-1.621	-125.19% (-2.03)
Apr 29, 2025	2024 (Q4)	-0.89 / -0.89	8.728	-110.18% (-9.62)
Sep 12, 2024	2024 (Q2)	-1.13 / -1.62	-1.897	14.56% (+0.28)
Apr 25, 2024	2023 (Q4)	- / 8.73	-2.557	441.31% (+11.28)
Sep 07, 2023	2023 (Q2)	-1.90 / -1.90	-6.291	69.85% (+4.39)
Apr 27, 2023	2022 (Q4)	- / -2.56	-2.761	7.39% (+0.20)
Oct 31, 2022	2022 (Q2)	- / -6.29	-11.074	43.19% (+4.78)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed